You are being asked to participate in this research study because you have been diagnosed with breast cancer and considered for immunotherapy. This study will investigate your response to immunotherapy.

If you are being considered for an EXIT procedure, you may be eligible to participate in our research study.

The purpose of this study is to see if batoclimab is safe and helps people with chronic inflammatory demyelinating polyneuropathy (CIDP), an autoimmune disorder. Batoclimab is also known as IMVT-1401. Batoclimab is injected under the skin (subcutaneously) and targets the immune system.

Do you have Alpha-1 Antitrypsin Deficiency? Do you want to participate in research? You may be able to participate in a research project to be contacted for future research studies. Compensation provided.

Have you recently had an anterior cruciate ligament injury and will be undergoing anterior cruciate ligament reconstruction surgery? If so, you may be able to participate in a study comparing the effects on pain relief and arthritis prevention of metformin or placebo. Compensation provided.

Do you have triple-negative breast cancer that either came back or did not improve after initial cancer treatment? If so, you may be able to take part in this gene therapy research study to learn more about using your own modified immune cells as a possible treatment.

Have you been diagnosed with Blood Cancer. If so, you may be able to take part in a research study looking at the safety of giving a new drug called AZD9829 to patients with Leukemia.

Can we extend your life after the diagnosis of your cancer in the stomach, esophagus, or gastroesophageal junction by adding a third chemotherapy drug to the usual combination of two chemotherapy drugs? We are doing this study because we want to find out if this approach is better or worse than the usual approach for treatment of your cancer in the stomach, esophagus, or gastroesophageal junction. The usual approach is defined as care most people get for cancer in the stomach, esophagus, or gastroesophageal junction.

Are you a young adult cancer survivor who would like to lose weight? Interested in using technology to support a healthy diet, get more physically active, and improve your mental health? Researchers at the University of North Carolina at Chapel Hill are looking for volunteers to sign up for a 6-month research program that will involve using a Fitbit activity tracker, digital smart scale, and mobile app. For more information and to see if you qualify, visit our study website at www.uncweightresearch.org

The iTREAT study will compare different ways of treating asthma: a pill or adding a second inhaler to see if they reduce the need for emergency care or going to the hospital.